Skip to content

Drug interactions

Crofelemer + Lapatinib

Severity: Minor

Crofelemer and Lapatinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Crofelemer is minimally absorbed but may inhibit CYP3A4 in the gut. A clinically meaningful rise in lapatinib exposure is unlikely, though possible.

What this interaction means in plain words

Crofelemer and Lapatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Crofelemer belongs to Gastrointestinal Tract; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Crofelemer may inhibit intestinal CYP3A4, slightly reducing first-pass metabolism of lapatinib.

What to do

No routine adjustment is needed. Monitor for lapatinib adverse effects such as diarrhea and QT prolongation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crofelemer and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crofelemer with Lapatinib?

MediHelp rates the interaction as minor. Crofelemer and Lapatinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Crofelemer is minimally absorbed but may inhibit CYP3A4 in the gut. A clinically meaningful rise in lapatinib exposure is unlikely, though possible.

How serious is the interaction between Crofelemer and Lapatinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed. Monitor for lapatinib adverse effects such as diarrhea and QT prolongation.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in